The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
iwMyeloma 2016 | The importance of the microenvironment in multiple myeloma
Faith Davies, MBBCh, MRCP, MD, FRCPath from UAMS Myeloma Institute, Arkansas, AZ discusses the importance of the microenvironemt in multiple myeloma at the Myeloma 2016 meeting held in Boston, MA. In light of findings that have established the importance of the microenvironment, Prof Davies further talks about the possibility of new drug combinations, such as combining HDAC inhibitors with immune check-point inhibitors.
